Haemovigilance: A Current Update in Indian Perspective

Haemovigilance is an organised scheme of monitoring, identifying, reporting, investigating and analysing adverse events and reactions pertinent to transfusion and manufacturing blood products. This system is also an elemental part of quality control in a blood system, bringing about corrective and...

Full description

Bibliographic Details
Main Authors: Somnath Mukherjee, Rituparna Maiti
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-11-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/8868/21029_CE[Ra]_F(P)_PF1(AH_Om)_PFA(AK)_PF2(OSM_P).pdf
id doaj-c86c4fd7be9b4e34a05cd891322b3e86
record_format Article
spelling doaj-c86c4fd7be9b4e34a05cd891322b3e862020-11-25T03:46:24ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-11-011011EE05EE0910.7860/JCDR/2016/21029.8868Haemovigilance: A Current Update in Indian PerspectiveSomnath Mukherjee0Rituparna Maiti1Associate Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.Associate Professor, Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.Haemovigilance is an organised scheme of monitoring, identifying, reporting, investigating and analysing adverse events and reactions pertinent to transfusion and manufacturing blood products. This system is also an elemental part of quality control in a blood system, bringing about corrective and preventive measures, and for the perpetual advancement of the quality and safety of blood products and the transfusion process. Nowadays haemovigilance setups have been enforced throughout the globe in most developed countries, to monitor the adverse reactions and episodes associated with blood donations and transfusions. Indian Pharmacopoeia Commission has started a Haemovigilance Program of India (HvPI) in 2012 under its Pharmacovigilance Program of India (PvPI) in collaboration with National Institute of Biologicals, Noida, Uttar Pradesh, under Ministry of Health and Family welfare, Government of India with a primary objective to track adverse reactions/events and incidences associated with blood transfusion and blood product administration and to identify trends, recommend best practices and interventions required to improve patient care and safety. This review article is a detail update of current scenario of haemovigilance in India. https://jcdr.net/articles/PDF/8868/21029_CE[Ra]_F(P)_PF1(AH_Om)_PFA(AK)_PF2(OSM_P).pdfadverse reactionimputabilitytransfusion practiceblood usage
collection DOAJ
language English
format Article
sources DOAJ
author Somnath Mukherjee
Rituparna Maiti
spellingShingle Somnath Mukherjee
Rituparna Maiti
Haemovigilance: A Current Update in Indian Perspective
Journal of Clinical and Diagnostic Research
adverse reaction
imputability
transfusion practice
blood usage
author_facet Somnath Mukherjee
Rituparna Maiti
author_sort Somnath Mukherjee
title Haemovigilance: A Current Update in Indian Perspective
title_short Haemovigilance: A Current Update in Indian Perspective
title_full Haemovigilance: A Current Update in Indian Perspective
title_fullStr Haemovigilance: A Current Update in Indian Perspective
title_full_unstemmed Haemovigilance: A Current Update in Indian Perspective
title_sort haemovigilance: a current update in indian perspective
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2016-11-01
description Haemovigilance is an organised scheme of monitoring, identifying, reporting, investigating and analysing adverse events and reactions pertinent to transfusion and manufacturing blood products. This system is also an elemental part of quality control in a blood system, bringing about corrective and preventive measures, and for the perpetual advancement of the quality and safety of blood products and the transfusion process. Nowadays haemovigilance setups have been enforced throughout the globe in most developed countries, to monitor the adverse reactions and episodes associated with blood donations and transfusions. Indian Pharmacopoeia Commission has started a Haemovigilance Program of India (HvPI) in 2012 under its Pharmacovigilance Program of India (PvPI) in collaboration with National Institute of Biologicals, Noida, Uttar Pradesh, under Ministry of Health and Family welfare, Government of India with a primary objective to track adverse reactions/events and incidences associated with blood transfusion and blood product administration and to identify trends, recommend best practices and interventions required to improve patient care and safety. This review article is a detail update of current scenario of haemovigilance in India.
topic adverse reaction
imputability
transfusion practice
blood usage
url https://jcdr.net/articles/PDF/8868/21029_CE[Ra]_F(P)_PF1(AH_Om)_PFA(AK)_PF2(OSM_P).pdf
work_keys_str_mv AT somnathmukherjee haemovigilanceacurrentupdateinindianperspective
AT rituparnamaiti haemovigilanceacurrentupdateinindianperspective
_version_ 1724506819626270720